@article{oai:niigata-u.repo.nii.ac.jp:00008440, author = {小杉, 伸一}, issue = {6}, journal = {新潟医学会雑誌, 新潟医学会雑誌}, month = {Jun}, note = {Surgery is still a mainstay of treatment for esophageal cancer; however, the 5-year overall survival of patients who underwent esophagectomy with 3-field lymphadenectomy is 40-50%, which implies the limilation of surgery as a local therapy. Since 1980s, the Japan Clinical Oncology Group) (JCOG) has conducted some multicenter randomized controlled trials to stablish a standard adjuvant therapy for this disease. Some representative JCOG studies and our relevant clinical studies are introduced and future perspectives are also discussed in this review.}, pages = {333--339}, title = {食道癌外科の変遷と今後の展望}, volume = {130}, year = {2016} }